461 related articles for article (PubMed ID: 30093193)
1. A Case of Adult-onset Pompe Disease with Cerebral Stroke and Left Ventricular Hypertrophy.
Hossain MA; Miyajima T; Akiyama K; Eto Y
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3046-3052. PubMed ID: 30093193
[TBL] [Abstract][Full Text] [Related]
2. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
Boentert M; Florian A; Dräger B; Young P; Yilmaz A
J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
[TBL] [Abstract][Full Text] [Related]
3. Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum.
Musumeci O; Thieme A; Claeys KG; Wenninger S; Kley RA; Kuhn M; Lukacs Z; Deschauer M; Gaeta M; Toscano A; Gläser D; Schoser B
Neuromuscul Disord; 2015 Sep; 25(9):719-24. PubMed ID: 26231297
[TBL] [Abstract][Full Text] [Related]
4. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
[TBL] [Abstract][Full Text] [Related]
5. Infantile Pompe disease with intrauterine onset: a case report and literature review.
Xi H; Li X; Ma L; Yin X; Yang P; Zhang L
Ital J Pediatr; 2022 Nov; 48(1):187. PubMed ID: 36411466
[TBL] [Abstract][Full Text] [Related]
6. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
[TBL] [Abstract][Full Text] [Related]
7. [Variability in the clinical presentation of Pompe disease in infancy: two case reports and response to treatment with human recombinant enzyme].
Moreno-Medinilla E; Berzosa-López R; Mora-Ramírez MD; Blasco-Alonso J; Martínez-Antón J
Rev Neurol; 2014 Dec; 59(11):503-7. PubMed ID: 25418145
[TBL] [Abstract][Full Text] [Related]
8. The frequency of late-onset Pompe disease in pediatric patients with limb-girdle muscle weakness and nonspecific hyperCKemia: A multicenter study.
Ünver O; Hacıfazlıoğlu NE; Karatoprak E; Güneş AS; Sağer G; Kutlubay B; Sözen G; Saltık S; Yılmaz K; Kara B; Türkdoğan D
Neuromuscul Disord; 2016 Nov; 26(11):796-800. PubMed ID: 27666774
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of Pompe disease.
Manganelli F; Ruggiero L
Acta Myol; 2013 Oct; 32(2):82-4. PubMed ID: 24399863
[TBL] [Abstract][Full Text] [Related]
10. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
Malhotra K; Carrington DC; Liebeskind DS
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy.
Korpela MP; Paetau A; Löfberg MI; Timonen MH; Lamminen AE; Kiuru-Enari SM
Muscle Nerve; 2009 Jul; 40(1):143-8. PubMed ID: 19472353
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease.
Mori M; Haskell G; Kazi Z; Zhu X; DeArmey SM; Goldstein JL; Bali D; Rehder C; Cirulli ET; Kishnani PS
Mol Genet Metab; 2017 Dec; 122(4):189-197. PubMed ID: 29122469
[TBL] [Abstract][Full Text] [Related]
13. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
[TBL] [Abstract][Full Text] [Related]
14. A genetic modifier of symptom onset in Pompe disease.
Bergsma AJ; In 't Groen SLM; van den Dorpel JJA; van den Hout HJMP; van der Beek NAME; Schoser B; Toscano A; Musumeci O; Bembi B; Dardis A; Morrone A; Tummolo A; Pasquini E; van der Ploeg AT; Pijnappel WWMP
EBioMedicine; 2019 May; 43():553-561. PubMed ID: 30922962
[TBL] [Abstract][Full Text] [Related]
15. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
16. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme.
Pascual SI
Adv Exp Med Biol; 2009; 652():39-46. PubMed ID: 20225018
[TBL] [Abstract][Full Text] [Related]
17. Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results.
Hamdan MA; Almalik MH; Mirghani HM
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S431-6. PubMed ID: 19067231
[TBL] [Abstract][Full Text] [Related]
18. First clinical and genetic description of a family diagnosed with late-onset Pompe disease from Costa Rica.
Torrealba-Acosta G; Rodríguez-Roblero MC; Bogantes-Ledezma S; Carazo-Céspedes K; Desnuelle C
Neuromuscul Disord; 2017 Oct; 27(10):951-955. PubMed ID: 28694071
[TBL] [Abstract][Full Text] [Related]
19. Late onset form of Pompe disease.
Mattosova S; Hlavata A; Spalek P; Kotysova L; Macekova D; Chandoga J
Bratisl Lek Listy; 2015; 116(8):502-5. PubMed ID: 26350092
[TBL] [Abstract][Full Text] [Related]
20. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
